Indian government caught unawares over flu pandemic

9 March 2015
gateway-of-india-big

The recent outbreak of infections and death caused by the influenza A H1N1 strain across India has turned the spotlight on the country's ailing health care system. Questions have been raised about how the government has been caught unawares yet again, despite the 2009 pandemic, when India recorded 981 deaths and 27,236 infection cases over a period of seven months, reports The Pharma Letter’s India correspondent.

India has already witnessed a high rate of mortality in the current season, which is only two months old. The outbreak this time, which started late December 2014, has already left 1,239 people dead, and over 23,153 infected.

A prolonged winter and unseasonal rainfall across the country has made early detection and management of swine flu extremely challenging. Swiss pharma major Roche’s (ROG: SIX) Tamiflu (oseltamivir), a Schedule X drug, is available only on prescription.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical